<DOC>
	<DOCNO>NCT01467934</DOCNO>
	<brief_summary>In study , investigator prospectively assess fever rate associate vaccine adverse event 6-23 month old patient day 0-7 administration trivalent inactivate influenza vaccine ( TIV ) 13-valent pneumococcal conjugate vaccine ( PCV13 ) concomitantly compare receive trivalent inactivate influenza vaccine ( TIV ) 13-valent pneumococcal conjugate vaccine ( PCV13 ) administer non-concomitantly . The investigator hypothesize fever rate significantly high 0-1 day vaccination inactivate influenza vaccine ( TIV ) 13-valent pneumococcal conjugate vaccine ( PCV13 ) give concomitantly TIV PCV13 administer non-concomitantly .</brief_summary>
	<brief_title>FeverText : Assessing Fever Rates After Vaccination During 2011-12 Influenza Season Using Text Messaging</brief_title>
	<detailed_description />
	<mesh_term>Fever</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<mesh_term>Heptavalent Pneumococcal Conjugate Vaccine</mesh_term>
	<criteria>1. 6 23 month old , 2. visit study site study period Nov. 1 , 2011 March 31 , 2012 , 3. receive trivalent inactivate influenza vaccine ( TIV ) /13valent pneumococcal conjugate vaccine ( PCV13 ) concomitantly , trivalent inactivate influenza vaccine ( TIV ) /without 13valent pneumococcal conjugate vaccine ( PCV13 ) 13valent pneumococcal conjugate vaccine ( PCV13 ) without trivalent inactivate influenza vaccine ( TIV ) / ( 4 ) parent cell phone text messaging capability ; ( 5 ) parent speak English Spanish . Exclusion criterion : 1. presence fever &gt; =100.4 time vaccination ; 2. administration antipyretic 6hour period prior vaccination 3. state intent use prophylactic antipyretic time vaccination development fever ; 4. state intention move away NYC area &lt; 6 month ; 5. parent speaks language English Spanish ; 6. inability read text message ; 7. child receive live attenuate influenza vaccine ( LAIV ) visit ; 8. child receive trivalent inactivate influenza vaccine ( TIV ) 13valent pneumococcal conjugate vaccine ( PCV13 ) seven day prior enrollment date Note : Patient may receive vaccine addition trivalent inactivate influenza vaccine ( TIV ) /13valent pneumococcal conjugate vaccine ( PCV13 )</criteria>
	<gender>All</gender>
	<minimum_age>6 Months</minimum_age>
	<maximum_age>23 Months</maximum_age>
	<verification_date>July 2014</verification_date>
</DOC>